International Conference on Rheumatology and Autoantibody Studies - (ICRAAS-26)


29th - 30th September, 2026 | Geneva, Switzerland

Multi-format (In-person/Virtual)

Submit for Presentation Attendee Registration Conference Brochure
Registration Options →

Explore conference registration categories designed for every mode of participation.

Home About Organizer Call For Paper Paper Submission Author Guidelines Registration Presentation Guidelines Organizing Committee Collaboration Agenda Do's and Dont's Invitation Letter Venue Contact Us

Important Dates

Pre-registration Deadline

30th August, 2026

Paper Submission Deadline

4th September, 2026

Last Date Of Registration

14th September, 2026

Date Of Conference

29th - 30th September, 2026

Downloads

Conference Flyer
Sample Abstract
Sample Full Paper

Call for Papers

The (ICRAAS-26) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Rheumatology, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Autoantibodies in rheumatic disease diagnosis
  • Role of autoantibodies in disease progression
  • Novel autoantibody testing methodologies
  • Clinical implications of autoantibody profiles
  • Autoantibodies and treatment responses
  • Genetic factors influencing autoantibody production
  • Autoantibody research in systemic diseases
  • Impact of environmental factors on autoimmunity
  • Autoantibodies and comorbid conditions
  • Therapeutic targets in autoantibody research
  • Longitudinal studies on autoantibody development
  • Autoantibodies in pediatric rheumatology
  • Ethical considerations in autoantibody research
  • Autoantibody prevalence in different populations
  • Role of autoantibodies in personalized medicine
  • Clinical trials involving autoantibody therapies
  • Autoantibody profiles in inflammatory arthritis
  • Impact of lifestyle on autoantibody levels
  • Future directions in autoantibody research
  • Collaboration between researchers and clinicians

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.

Submit Your Paper Today Register Early & Reserve Your Slot